Package 46708-525-25

Brand: doxorubicin hydrochloride

Generic: doxorubicin hydrochloride
NDC Package

Package Facts

Identity

Package NDC 46708-525-25
Digits Only 4670852525
Product NDC 46708-525
Description

1 VIAL, SINGLE-DOSE in 1 CARTON (46708-525-25) / 25 mL in 1 VIAL, SINGLE-DOSE

Marketing

Marketing Status
Marketed Since 2025-06-27
Brand doxorubicin hydrochloride
Generic doxorubicin hydrochloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "f8e001f5-441c-47cd-86f6-5d5e3de16bc0", "openfda": {"unii": ["82F2G7BL4E"], "rxcui": ["1790115", "1790127"], "spl_set_id": ["f8e001f5-441c-47cd-86f6-5d5e3de16bc0"], "manufacturer_name": ["Alembic Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (46708-525-25)  / 25 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "46708-525-25", "marketing_start_date": "20250627"}], "brand_name": "doxorubicin hydrochloride", "product_id": "46708-525_f8e001f5-441c-47cd-86f6-5d5e3de16bc0", "dosage_form": "INJECTION, SUSPENSION, LIPOSOMAL", "pharm_class": ["Anthracycline Topoisomerase Inhibitor [EPC]", "Anthracyclines [CS]", "Topoisomerase Inhibitors [MoA]"], "product_ndc": "46708-525", "generic_name": "doxorubicin hydrochloride", "labeler_name": "Alembic Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "doxorubicin hydrochloride", "active_ingredients": [{"name": "DOXORUBICIN HYDROCHLORIDE", "strength": "2 mg/mL"}], "application_number": "ANDA219199", "marketing_category": "ANDA", "marketing_start_date": "20250627", "listing_expiration_date": "20261231"}